Supplied strictly for in-vitro and laboratory research. Not for human or veterinary use. By ordering, you confirm you are a qualified researcher handling these materials per applicable regulations and safe lab practice.
Hexarelin is a synthetic hexapeptide and a potent ghrelin-receptor agonist studied for its strong stimulation of growth-hormone release. Beyond the endocrine axis, it is also of interest in cardiovascular signaling research, where it acts through additional receptor targets.
Developed by Mediolanum Farmaceutici under the codes EP-23905 and MF-6003, hexarelin was characterized in the 1990s for its growth-hormone-releasing activity. Later research examined its cardiovascular signaling through both the growth-hormone-secretagogue receptor and CD36, extending interest beyond its original endocrine profile.
Hexarelin has been studied in endocrine and cardiovascular models for GHS-receptor and CD36 agonism, growth-hormone-pulse stimulation, anti-apoptotic signaling, and cardiac-protection pathways. What sets hexarelin apart as a research tool is its dual reach into endocrine and cardiovascular signaling through more than one receptor. That makes it useful not only for growth-hormone studies but also for probing CD36-mediated and cardioprotective pathways in laboratory models.
Manufactured in a controlled U.S. facility under strict compounding standards.
Every batch third-party tested with HPLC and mass spectrometry.
Orders dispatched same-day from our U.S. facility.
Reach out and get a response within minutes.
Everything you need to know about our products and processes.